Search Results - Giancarlo Pruneri

Refine Results
  1. 1

    Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications by Emma Zattarin, Rita Leporati, Francesca Ligorio, Riccardo Lobefaro, Andrea Vingiani, Giancarlo Pruneri, Claudio Vernieri

    Published in Cells (2020-12-01)
    Get full text
    Article


  2. 2

    Genomic and transcriptomic analyses of thyroid cancers identify DICER1 somatic mutations in adult follicular-patterned RAS-like tumors by Emanuela Minna, Emanuela Minna, Andrea Devecchi, Federico Pistore, Biagio Paolini, Giuseppe Mauro, Donata Alda Penso, Sonia Pagliardini, Adele Busico, Giancarlo Pruneri, Giancarlo Pruneri, Loris De Cecco, Maria Grazia Borrello, Marialuisa Sensi, Angela Greco

    Published in Frontiers in Endocrinology (2023-10-01)
    Get full text
    Article


  3. 3

    Pre‐clinical validation of a selective anti‐cancer stem cell therapy for Numb‐deficient human breast cancers by Daniela Tosoni, Sarah Pambianco, Blanche Ekalle Soppo, Silvia Zecchini, Giovanni Bertalot, Giancarlo Pruneri, Giuseppe Viale, Pier Paolo Di Fiore, Salvatore Pece

    Published in EMBO Molecular Medicine (2017-03-01)
    Get full text
    Article


  4. 4

    Comprehensive transcriptomic analysis to identify biological and clinical differences in cholangiocarcinoma by Marco Silvestri, Trung Nghia Vu, Federico Nichetti, Monica Niger, Serena Di Cosimo, Filippo De Braud, Giancarlo Pruneri, Yudi Pawitan, Stefano Calza, Vera Cappelletti

    Published in Cancer Medicine (2023-04-01)
    Get full text
    Article


  5. 5

    The central role of pathology labs in breast cancer precision oncology: a call for action by Giancarlo Pruneri, Daniele Lorenzini, Mauro G. Mastropasqua, Giuseppe Perrone, Antonio Rizzo, Donatella Santini, Chiara C. Volpi, Saverio Cinieri, Alberto Zambelli, Anna Sapino, Isabella Castellano

    Published in npj Breast Cancer (2023-01-01)
    Get full text
    Article


  6. 6

    Prevalence of BRCA homopolymeric indels in an ION Torrent-based tumour-to-germline testing workflow in high-grade ovarian carcinoma by Jacopo Azzollini, Luca Agnelli, Elena Conca, Tommaso Torelli, Adele Busico, Iolanda Capone, Marta Angelini, Elena Tamborini, Federica Perrone, Andrea Vingiani, Daniele Lorenzini, Bernard Peissel, Giancarlo Pruneri, Siranoush Manoukian

    Published in Scientific Reports (2023-05-01)
    Get full text
    Article


  7. 7

    Development of Personalized Therapeutic Strategies by Targeting Actionable Vulnerabilities in Metastatic and Chemotherapy-Resistant Breast Cancer PDXs by Simona Punzi, Marine Meliksetian, Laura Riva, Federica Marocchi, Giancarlo Pruneri, Carmen Criscitiello, Franco Orsi, Lorenzo Spaggiari, Monica Casiraghi, Paolo Della Vigna, Lucilla Luzi, Giuseppe Curigliano, Pier Giuseppe Pelicci, Luisa Lanfrancone

    Published in Cells (2019-06-01)
    Get full text
    Article


  8. 8

    Genomic instability and CCNE1 amplification as emerging biomarkers for stratifying high-grade serous ovarian cancer by Elena Conca, Daniele Lorenzini, Daniele Lorenzini, Emanuela Minna, Luca Agnelli, Matteo Duca, Marco Gentili, Beatrice Bodini, Maggie Polignano, Mara Mantiero, Silvia Damian, Andrea Devecchi, Gianpaolo Dagrada, Rita Carminati, Alice Ardore, Francesca Barbetta, Nathalia Brito Da Chuna, Andrea Guerrizio, Adele Busico, Iolanda Capone, Alberta Piccolo, Elena Tamborini, Federica Perrone, Massimo Milione, Biagio Paolini, Andrea Vingiani, Andrea Vingiani, Francesco Raspagliesi, Francesco Raspagliesi, Filippo De Braud, Filippo De Braud, Giancarlo Pruneri, Giancarlo Pruneri

    Published in Frontiers in Oncology (2025-08-01)
    Get full text
    Article


  9. 9

    Advancing breast cancer therapy in the era of molecular diagnostics by Maria Grazia Carnevale, Riccardo Ray Colciago, Maria Carmen De Santis, Laura Cortesi, Cinzia De Marco, Antonio Marra, Andrea Vingiani, Franco Nolè, Giuseppe Curigliano, Giancarlo Pruneri, Antonio Llombart-Cussac, Serena Di Cosimo, Javier Cortes

    Published in Breast (2025-08-01)
    Get full text
    Article


  10. 10

    Extraction of a stromal metastatic gene signature in breast cancer via spatial profiling by Giorgio Bertolazzi, Valeria Cancila, Davide Vacca, Beatrice Belmonte, Daniele Lecis, Parsa Sirati Moghaddam, Arianna Di Napoli, Mario Paolo Colombo, Giancarlo Pruneri, Giannino Del Sal, Giorgio Scita, Matteo Fassan, Andrea Vecchione, Silvio Bicciato, Claudio Tripodo

    Get full text
    Article


  11. 11

    Detecting gene copy number alterations by Oncomine Comprehensive genomic profiling in a comparative study on FFPE tumor samples by Fabio Bozzi, Elena Conca, Marco Silvestri, Gianpaolo Dagrada, Alice Ardore, Donata Penso, Daniele Lorenzini, Chiara Costanza Volpi, Desirè Viola Trupia, Adele Busico, Iolanda Capone, Federica Perrone, Elena Tamborini, Andrea Vingiani, Luca Agnelli, Giancarlo Pruneri

    Published in Scientific Reports (2025-02-01)
    Get full text
    Article


  12. 12

    Identification of <i>PSMB4</i> and <i>PSMD4</i> as novel target genes correlated with 1q21 amplification in patients with smoldering myeloma and multiple myeloma by Jessica Burroughs Garcia, Paola Storti, Nicolas Thomas Iannozzi, Valentina Marchica, Luca Agnelli, Denise Toscani, Valentina Franceschi, Giannalisa Todaro, Gabriella Sammarelli, Laura Notarfranchi, Matteo Scita, Benedetta Dalla Palma, Vincenzo Raimondi, Oxana Lungu, Giancarlo Pruneri, Gaetano Donofrio, Nicola Giuliani

    Published in Haematologica (2023-08-01)
    Get full text
    Article


  13. 13

    A gene expression-based classifier for HER2-low breast cancer by Serena Di Cosimo, Sara Pizzamiglio, Chiara Maura Ciniselli, Valeria Duroni, Vera Cappelletti, Loris De Cecco, Cinzia De Marco, Marco Silvestri, Maria Carmen De Santis, Andrea Vingiani, Biagio Paolini, Rosaria Orlandi, Marilena Valeria Iorio, Giancarlo Pruneri, Paolo Verderio

    Published in Scientific Reports (2024-02-01)
    Get full text
    Article


  14. 14

    ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC). by Lorenzo Ferrando, Andrea Vingiani, Anna Garuti, Claudio Vernieri, Antonino Belfiore, Luca Agnelli, Gianpaolo Dagrada, Diana Ivanoiu, Giuseppina Bonizzi, Elisabetta Munzone, Luana Lippolis, Martina Dameri, Francesco Ravera, Francesco Ravera, Marco Colleoni, Giuseppe Viale, Luca Magnani, Alberto Ballestrero, Gabriele Zoppoli, Giancarlo Pruneri

    Published in PLoS Genetics (2023-01-01)
    Get full text
    Article


  15. 15

    Circulating tumor DNA to anticipate loco-regional recurrence in early-stage breast cancer: a proof-of-concept study by Valentina Appierto, Elena Tamborini, Paola Tiberio, Adele Busico, Loris De Cecco, Marco Silvestri, Marco Silvestri, Cinzia De Marco, Elena Cavadini, Maria Carmen De Santis, Maria Carmen De Santis, Secondo Folli, Gianfranco Scaperrotta, Rebecca Manitto, Andrea Vingiani, Giancarlo Pruneri, Serena Di Cosimo

    Published in Frontiers in Oncology (2025-09-01)
    Get full text
    Article


  16. 16

    Targeted RNA-sequencing analysis for fusion transcripts detection in tumor diagnostics: assessment of bioinformatic tools reliability in FFPE samples by Iolanda Capone, Fabio Bozzi, Gian Paolo Dagrada, Paolo Verderio, Elena Conca, Adele Busico, Maria Adele Testi, Valentina Monti, Matteo Duca, Claudia Proto, Silvia Damian, Alberta Piccolo, Federica Perrone, Elena Tamborini, Andrea Devecchi, Paola Collini, Daniele Lorenzini, Andrea Vingiani, Luca Agnelli, Giancarlo Pruneri

    Published in Exploration of Targeted Anti-tumor Therapy (2022-10-01)
    Get full text
    Article


  17. 17

    Gastroblastoma in Adulthood—A Rarity among Rare Cancers—A Case Report and Review of the Literature by Giovanni Centonze, Alessandro Mangogna, Tiziana Salviato, Beatrice Belmonte, Laura Cattaneo, Melissa Anna Teresa Monica, Giovanna Garzone, Cecilia Brambilla, Alessio Pellegrinelli, Flavia Melotti, Adele Testi, Valentina Monti, Ketevani Kankava, Patrizia Gasparini, Gianpaolo Dagrada, Vincenzo Mazzaferro, Christian Cotsoglou, Paola Collini, Giancarlo Pruneri, Massimo Milione

    Published in Case Reports in Pathology (2019-01-01)
    Get full text
    Article


  18. 18

    <i>CDKN2A</i> deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) by Francesco Maura, Anna Dodero, Cristiana Carniti, Niccolò Bolli, Martina Magni, Valentina Monti, Antonello Cabras, Daniel Leongamornlert, Federico Abascal, Benjamin Diamond, Bernardo Rodriguez-Martin, Jorge Zamora, Adam Butler, Inigo Martincorena, Jose M. C. Tubio, Peter J. Campbell, Annalisa Chiappella, Giancarlo Pruneri, Paolo Corradini

    Published in Haematologica (2020-09-01)
    Get full text
    Article


  19. 19

    End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTO by Serena Di Cosimo, Chiara M. Ciniselli, Sara Pizzamiglio, Vera Cappelletti, Marco Silvestri, Sarra El-Abed, Miguel Izquierdo, Mohammed Bajji, Paolo Nuciforo, Jens Huober, Jens Huober, David Cameron, Stephen Chia, Henry L. Gomez, Henry L. Gomez, Marilena V. Iorio, Andrea Vingiani, Giancarlo Pruneri, Paolo Verderio

    Published in Frontiers in Oncology (2023-01-01)
    Get full text
    Article


  20. 20

    Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial by Teresa Maria Rosaria Noviello, Anna Maria Di Giacomo, Francesca Pia Caruso, Alessia Covre, Roberta Mortarini, Giovanni Scala, Maria Claudia Costa, Sandra Coral, Wolf H. Fridman, Catherine Sautès-Fridman, Silvia Brich, Giancarlo Pruneri, Elena Simonetti, Maria Fortunata Lofiego, Rossella Tufano, Davide Bedognetti, Andrea Anichini, Michele Maio, Michele Ceccarelli

    Published in Nature Communications (2023-09-01)
    Get full text
    Article


Search Tools: